Compound Profile: BOLDEBET BETHA PHARMA
Boldebet by Betha Pharma is a veterinary anabolic steroid injection containing boldenone undecylenate, originally developed for equine applications. This compound represents a testosterone derivative with modified anabolic properties that researchers at Stroid UK Shop investigate for its unique pharmacological profile. Boldenone undecylenate exhibits an extended half-life due to the undecylenate ester attachment, making it valuable for studies requiring sustained compound exposure in laboratory models. The veterinary formulation provides researchers with access to pharmaceutical-grade material for examining anabolic pathways, protein synthesis mechanisms, and androgenic receptor interactions in controlled research environments.
Laboratory Applications
Research scientists examine Boldebet for its distinctive anabolic-to-androgenic ratio compared to testosterone and other compounds available through our boldenone injection collection. The compound demonstrates moderate anabolic activity with reduced androgenic effects in animal models, making it useful for comparative studies with other research compounds. Laboratory investigations focus on its effects on nitrogen retention, red blood cell production, and muscle protein synthesis pathways. Researchers also study its aromatisation patterns, as boldenone converts to estradiol at approximately half the rate of testosterone, providing insights into estrogen-mediated anabolic processes. Studies examining the compound alongside selective androgen receptor modulators help elucidate tissue-specific androgenic signalling pathways.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Boldenone Undecylenate |
| Manufacturer | Betha Pharma |
| Formulation | Injectable Solution |
| Storage Requirements | Room temperature, protect from light |
| Molecular Formula | C₃₀H₄₄O₃ |
| Molecular Weight | 452.68 g/mol |
| CAS Number | 13103-34-9 |
| Research Grade | Veterinary pharmaceutical |
This veterinary-grade formulation ensures consistent quality for researchers studying anabolic steroid mechanisms alongside other research compounds including research peptides in comparative endocrinology studies.
Research Compliance Statement
Boldebet by Betha Pharma is supplied strictly for in-vitro research and laboratory analysis purposes only. This veterinary pharmaceutical product is not intended for human consumption, therapeutic use, or administration to animals outside controlled research settings. Researchers must comply with all applicable laboratory safety protocols and institutional guidelines when handling this compound. The product should only be used by qualified research professionals in appropriate laboratory facilities equipped for pharmaceutical research. All studies involving this material must adhere to relevant research ethics standards and regulatory requirements governing controlled substances in research environments.
